Skip to Content

LDK 150MG NVR (Zykadia 150 mg)

Generic Name: ceritinib

Pill with imprint LDK 150MG NVR is Blue & White, Capsule-shape and has been identified as Zykadia 150 mg. It is supplied by Novartis Pharmaceuticals Corporation.

Zykadia is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Zykadia 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for LDK 150MG NVR

Zykadia

Generic Name:
ceritinib
Imprint:
LDK 150MG NVR
Strength:
150 mg
Color:
Blue & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals Corporation
National Drug Code (NDC):
00078-0640

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide